Related Experiment Videos
Approaches to improve angiogenesis in tissue-engineered skin
Parbinder S Sahota1, J Lance Burn, Nicola J Brown
1Section of Human Metabolism, Division of Clinical Sciences, Northern General Hospital, Sheffield, UK. s.macneil@sheffield.ac.uk
Summary
Improving vascularization in tissue-engineered skin grafts is crucial for clinical success. This study found that hypoxia and adding endothelial cells to the papillary surface significantly enhance their penetration into engineered skin.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Clinical failure of tissue-engineered skin grafts is often caused by delayed vascularization.
- Effective angiogenesis is essential for the survival and integration of engineered tissues.
Purpose of the Study:
- To investigate simple strategies for improving angiogenesis and vascularization in a tissue-engineered skin model.
- To identify key factors influencing endothelial cell penetration into engineered dermal matrices.
Main Methods:
- Utilized a modified Guirguis chamber to test multiple variables simultaneously within the same human dermis.
- Assessed endothelial cell (small vessel human dermal microvascular endothelial cells) penetration using a qualitative scoring system.
- Examined the effects of cell type, growth factors, co-cultured cells (keratinocytes, fibroblasts), mechanical penetration, addition site, and hypoxia.
Main Results:
- Endothelial cell penetration was not improved by adding angiogenic growth factors (VEGF, bFGF), keratinocytes, fibroblasts, or mechanical perforation.
- A minimum cell seeding density was identified for effective penetration.
- Hypoxia and addition of endothelial cells to the papillary surface significantly enhanced dermal penetration.
Conclusions:
- This tissue-engineered skin model is valuable for understanding vascularization mechanisms.
- Hypoxia and strategic endothelial cell placement are key factors for promoting angiogenesis in engineered skin grafts.
- Findings provide insights for improving the clinical viability of tissue-engineered skin substitutes.